Metabolism of Macronutrients and the Maintenance of DNA Integrity

Gregor Lindner^*
*Correspondence: Gregor Lindner, Department of Emergency Medicine, University of Bern, Bern, Switzerland, Email:

Keywords

Immune function • Cardiovascular events • Cell growth • Coronary artery disease

Introduction

Vitamin D is a fat-soluble vitamin that plays a role in bone health, immune function, and cardiovascular health. The active form has been shown to have anti-inflammatory and anti-atherosclerotic effects. Several observational studies have suggested that low levels of vitamin D are associated with an increased risk of CVD. One large meta-analysis of 19 observational studies found that low levels of vitamin D were associated with a increased risk of CVD. However, randomized controlled trials of vitamin D supplementation have yielded mixed results. One RCT found that vitamin D supplementation reduced the risk of heart failure by in older adults, while another RCT found no significant reduction in the risk of major adverse cardiovascular events. Vitamin C, also known as ascorbic acid, is a water-soluble vitamin that acts as an antioxidant in the body. It is involved in many physiological processes, including collagen synthesis, wound healing and immune function. Some studies have suggested that vitamin C may also play a role in the prevention of CVD [1].

Literature Review

One observational study found that individuals with higher vitamin C intake had a lower risk of coronary heart disease than those with lower intake. Another study found that high-dose vitamin C supplementation reduced arterial stiffness in individuals with high blood pressure. However, other studies have found no significant association between vitamin C intake and CVD risk. The recommended daily intake of vitamin C for adults, with higher doses recommended for individuals who smoke or have certain medical conditions. Vitamin E is a fatsoluble vitamin that acts as an antioxidant in the body. It is involved in many physiological processes, including immune function and the maintenance of cell membranes. Some studies have suggested that vitamin E may also play a role in the prevention of CVD [2].

Discussion

One large meta-analysis of 14 observational studies found that higher intake of vitamin E was associated with a lower risk of coronary heart disease. However, RCTs of vitamin E supplementation have yielded mixed results. Some studies have suggested that vitamin E supplementation may reduce the risk of CVD in certain populations, such as individuals with diabetes or a history of heart disease. However, other studies have found no significant effect of vitamin E supplementation on CVD risk. B vitamins are a group of water-soluble vitamins that play a role in many physiological processes, including the metabolism of macronutrients and the maintenance of DNA integrity. Some B vitamins, including folate, vitamin have been studied in relation to CVD risk. Vitamins are essential micronutrients that the body requires in small amounts to maintain health and prevent disease. While vitamins are often associated with benefits such as boosting immunity and preventing deficiencies, research has also shown that some vitamins may play a role in reducing the risk of cardiovascular disease (CVD) [3].

CVD is a broad term that encompasses a range of conditions that affect the heart and blood vessels, including coronary artery disease, heart failure, and stroke. CVD is the leading cause of death worldwide, with an estimated 17.9 million deaths annually. Vitamin A is a fat-soluble vitamin that is important for vision, immune function, and cell growth and differentiation. Some studies have suggested that vitamin A may play a role in reducing the risk of CVD through its antioxidant properties. Antioxidants help to neutralize free radicals, unstable molecules that can damage cells and contribute to the development of chronic diseases, including CVD. However, other studies have suggested that excessive intake of vitamin A may increase the risk of CVD. One study found that men who consumed high doses of vitamin A supplements had a higher risk of developing CVD than those who did not take supplements. It is important to note that these findings were based on supplement use, and not on dietary intake of vitamin A, which is considered safe and beneficial [4].

Vitamin C is an essential water-soluble vitamin that is important for immune function, collagen synthesis, and wound healing. It is also a powerful antioxidant that can help to neutralize free radicals and reduce inflammation, both of which are thought to contribute to the development of CVD. Several studies have suggested that vitamin C may play a role in reducing the risk of CVD. For example, a study of over 85,000 women found that those with higher vitamin C intake had a lower risk of coronary artery disease than those with lower intake. Similarly, a study of over 10,000 men found that those with higher vitamin C intake had a lower risk of stroke than those with lower intake. However, not all studies have found a significant association between vitamin C and CVD risk. A meta-analysis of 44 randomized controlled trials found no significant effect of vitamin C supplementation on CVD outcomes [5].

Vitamin D is a fat-soluble vitamin that is important for bone health, immune function, and calcium homeostasis. It is also thought to play a role in reducing the risk of CVD by reducing inflammation, improving endothelial function, and reducing the risk of hypertension. Several observational studies have suggested that low levels of vitamin D are associated with an increased risk of CVD. For example, a study of over 1,700 adults found that those with low vitamin D levels had a higher risk of CVD events than those with normal levels. Similarly, a metaanalysis of 19 observational studies found that individuals with low vitamin D levels had a higher risk of hypertension than those with normal levels. However, randomized controlled trials of vitamin D supplementation have produced mixed results. Some studies have suggested that vitamin D supplementation may reduce the risk of CVD events, while others have found no significant effect [6].

Conclusion

Vitamin E is a fat-soluble vitamin that is important for immune function and acts as an antioxidant to neutralize free radicals. It is also thought to play a role in reducing the risk of CVD by reducing inflammation and preventing the oxidation of LDL cholesterol, a key step in the development of atherosclerosis. They can be found in a variety of foods, including fruits, vegetables, and whole grains. Some specific types of polyphenols, such as resveratrol found in red wine and catechins found in green tea, have been shown to have a particularly strong protective effect against cardiovascular disease. Similarly, dietary interventions that increase the consumption of antioxidant-rich foods, such as fruits and vegetables, may also be beneficial in reducing oxidative stress and improving cardiovascular outcomes. One of the ways in which oxidative stress contributes to CVD is through the oxidation of low-density lipoprotein cholesterol.

Acknowledgement

None.

Conflict of Interest

None.

References

1. La Meir, Mark, Sandro Gelsomino, Fabiana Lucà and Laurant Pison, et al. "Minimally invasive surgical treatment of lone atrial fibrillation: Early results of hybrid versus standard minimally invasive approach employing radiofrequency sources."Int J Cardiol 167 (2013): 1469-1475.

Google Scholar, Crossref, Indexed at

2. Gelsomino, Sandro, Domenico Corradi, Roberto Lorusso and Orlando Parise, et al. "Anatomical basis of minimally invasive epicardial ablation of atrial fibrillation."Eur J Cardiothorac Surg43 (2013): 673-682.

Google Scholar, Crossref, Indexed at

3. Lachman, Nirusha, Faisal F. Syed, Ammar Habib and Suraj Kapa, et al. "Correlative anatomy for the electrophysiologist, Part I: The pericardial space, oblique sinus, transverse sinus."J Cardiovasc Electrophysiol21 (2010): 1421-1426.

Google Scholar, Crossref, Indexed at

4. Litwinowicz, Radoslaw, Marian Burysz, Piotr Mazur and Boguslaw Kapelak, et al. "Endocardial vs. epicardial left atrial appendage exclusion for stroke prevention in patients with atrial fibrillation: Midterm follow‐up."J Cardiovasc Electrophysiol 32 (2021): 93-101.

Google Scholar, Crossref, Indexed at

5. Burysz, Marian, Radosław Litwinowicz, Magdalena Bryndza and Radomir Skowronek, et al. "Percutaneous left atrial appendage closure using the LAmbre device. First clinical results in Poland."Interv Cardiol 15 (2019): 251-254.

Google Scholar, Crossref, Indexed at

6. Baudo, Massimo, Rocco Davide Petruccelli, Michele D'Alonzo and Fabrizio Rosati, et al. "Rhythm outcomes of minimally-invasive off-pump surgical vs. catheter ablation in atrial fibrillation: A meta-analysis of reconstructed time-to-event data."Int J Cardiol 376 (2023): 62-75.

Google Scholar, Crossref, Indexed at